SAT-646 Double Jeopardy: Worse Outcomes and Higher Costs in DKA Patients with CKD

Authors

• Sara Iftikhar, Greater Baltimore Medical Center (GBMC)
• Tanvi Jain, Greater Baltimore Medical Centre, Towson, MD, USA
• Kainat Zulqadar, Greater Baltimore Medical Center (GBMC)
• Anoshia Farid, Greater Baltimore Medical Center (GBMC)
• Nadim Jaafar, Greater Baltimore Medical Center, Towson, Maryland, USA
• Ruth Horowitz, Greater Baltimore Medical Center (GBMC)

Document Type

Article

Publication Title

Journal of Endocrine Society

DOI

https://doi.org/10.1210/jendso/bvaf149.1169

Publication Date

10-22-2025

Comments

Iftikhar S, Jain T, Zulqadar K, Farid A, Jaafar N, Horowitz R. SAT-646 Double Jeopardy: Worse Outcomes and Higher Costs in DKA Patients with CKD. J Endocr Soc. 2025 Oct 22;9(Suppl 1):bvaf149.1169. doi: 10.1210/jendso/bvaf149.1169. PMCID: PMC12544045.

Recommended Citation

Iftikhar S, Jain T, Zulqadar K, Farid A, Jaafar N, Horowitz R. SAT-646 Double Jeopardy: Worse Outcomes and Higher Costs in DKA Patients with CKD. J Endocr Soc. 2025 Oct 22;9(Suppl 1):bvaf149.1169. doi: 10.1210/jendso/bvaf149.1169. PMCID: PMC12544045.